Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 
 

 

  Federal Register  

Link:  Pharm/Biotech Resources
 


Notice: Grant of Authority for Subzone Status; Noramco, Inc. 
(Pharmaceutical Intermediates), Athens, GA
Federal Register: October 9, 2008 (Volume 73, Number 197)            
                  Page 59598
Agency:  DEPARTMENT OF COMMERCE
         Foreign-Trade Zones Board


    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:

    Whereas, the Foreign-Trade Zones Act provides for ``* * * the 
establishment * * * of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs and Border Protection ports of 
entry;
    Whereas, the Board's regulations (15 CFR part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved, and when the activity results 
in a significant public benefit and is in the public interest;
    Whereas, the Georgia Foreign Trade Zone, Inc., grantee of FTZ 26, 
has made application to the Board for authority to establish special-
purpose subzone status at the pharmaceutical intermediate manufacturing 
plant of Noramco, Inc., located in Athens, Georgia (FTZ Docket 23-2008, 
filed 4/3/08);
    Whereas, notice inviting public comment has been given in the 
Federal Register (73 FR 20247, 4/15/08); and,
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that approval of the 
application is in the public interest;
    Now, therefore, the Board hereby grants authority for subzone 
status for activity related to a prescription pharmaceutical 
intermediate product at the Noramco, Inc., facility located in Athens, 
Georgia (Subzone 26K), as described in the application and Federal 
Register notice, and subject to the FTZ Act and the Board's 
regulations, including Section 400.28.

    Signed at Washington, DC, this 1st day of October 2008.
David M. Spooner,
Assistant Secretary of Commerce for Import Administration, Alternate 
Chairman, Foreign-Trade Zones Board.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E8-23888 Filed 10-8-08; 8:45 am]

BILLING CODE 3510-DS-P

      

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]